Signaturefd, LLC Neurocrine Biosciences Inc Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Signaturefd, LLC holds 2,636 shares of NBIX stock, worth $363,398. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,636

Previous 2,724 3.23%

Holding current value

$363,398

Previous $375,000 19.2%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$114.58 - $153.15 $10,083 - $13,477	-88 Reduced 3.23%	2,636 $303,000
Q2 2024 Jul 29, 2024	BUY	$130.86 - $143.19 $21,199 - $23,196	162 Added 6.32%	2,724 $375,000
Q1 2024 May 03, 2024	BUY	$130.4 - $143.74 $6,650 - $7,330	51 Added 2.03%	2,562 $353,000
Q4 2023 Jan 31, 2024	BUY	$106.07 - $132.76 $13,258 - $16,595	125 Added 5.24%	2,511 $330,000
Q3 2023 Nov 03, 2023	BUY	$94.02 - $117.1 $187,099 - $233,029	1,990 Added 502.53%	2,386 $268,000
Q2 2023 Aug 01, 2023	SELL	$89.53 - $104.87 $3,581 - $4,194	-40 Reduced 9.17%	396 $37,000
Q1 2023 Apr 28, 2023	BUY	$94.11 - $123.02 $14,210 - $18,576	151 Added 52.98%	436 $44,000
Q4 2022 Jan 27, 2023	BUY	$106.72 - $127.06 $2,881 - $3,430	27 Added 10.47%	285 $34,000
Q3 2022 Nov 08, 2022	SELL	$92.03 - $107.81 $2,392 - $2,803	-26 Reduced 9.15%	258 $27,000
Q2 2022 Aug 10, 2022	SELL	$75.79 - $100.07 $909 - $1,200	-12 Reduced 4.05%	284 $28,000
Q1 2022 May 02, 2022	BUY	$72.45 - $94.81 $3,042 - $3,982	42 Added 16.54%	296 $28,000
Q4 2021 Jan 25, 2022	SELL	$79.65 - $106.22 $34,329 - $45,780	-431 Reduced 62.92%	254 $22,000
Q3 2021 Oct 28, 2021	SELL	$86.18 - $99.03 $172 - $198	-2 Reduced 0.29%	685 $66,000
Q2 2021 Jul 26, 2021	BUY	$89.43 - $102.27 $626 - $715	7 Added 1.03%	687 $67,000
Q1 2021 Apr 30, 2021	SELL	$87.57 - $119.4 $1,225 - $1,671	-14 Reduced 2.02%	680 $66,000
Q4 2020 Feb 11, 2021	SELL	$86.91 - $108.33 $91,081 - $113,529	-1,048 Reduced 60.16%	694 $67,000
Q3 2020 Nov 03, 2020	BUY	$96.16 - $135.15 $10,192 - $14,325	106 Added 6.48%	1,742 $168,000
Q2 2020 Jul 30, 2020	BUY	$85.09 - $130.36 $6,296 - $9,646	74 Added 4.74%	1,636 $200,000
Q1 2020 Apr 23, 2020	BUY	$75.11 - $113.76 $9,914 - $15,016	132 Added 9.23%	1,562 $135,000
Q4 2019 Feb 05, 2020	BUY	$86.8 - $118.57 $7,030 - $9,604	81 Added 6.0%	1,430 $154,000
Q2 2019 Jul 31, 2019	BUY	$72.24 - $91.27 $722 - $912	10 Added 0.75%	1,349 $114,000
Q4 2018 Feb 13, 2019	BUY	$68.32 - $124.36 $68 - $124	1 Added 0.07%	1,339 $96,000
Q3 2018 Nov 15, 2018	BUY	$98.88 - $125.85 $98,880 - $125,850	1,000 Added 295.86%	1,338 $165,000
Q1 2018 May 08, 2018	BUY	$75.88 - $92.43 $25,647 - $31,241	338 New	338 $28,000

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account